Show ratings & reviews for

3.7 Overall Rating

Effectiveness

Tooltip icon

Ease of Use

Tooltip icon

Satisfaction

Tooltip icon

Most voted positive review

3 People found this comment helpful

Extraordinarily effective with minimal side effects. Fatigue is the worst. For those who must pay it is very expensive.

Most voted negative review

1 People found this comment helpful

My disease progressed through treatment in 3 months as evidenced by a new bony metastasis. Sorta lives up to it's Kaplan-Meyer curve of an additional 6 months in the intent to treat trials. Overall well tolerated though the hot flashes were difficult as was the constant nausea.

Shared reviews and ratings

Athol | 65-74 | Male | On medication for 1 to 6 months | Patient
11/21/2014
Condition: Metastatic Castration-Resistant Prostate Cancer
Overall rating 5.0
Effectiveness
Ease of Use
Satisfaction

Extraordinarily effective with minimal side effects. Fatigue is the worst. For those who must pay it is very expensive.

Report this postFill 3Created with Sketch.
Puck | 55-64 | Male | On medication for 1 to 6 months | Patient
4/22/2013
Condition: Metastatic Castration-Resistant Prostate Cancer
Overall rating 2.3
Effectiveness
Ease of Use
Satisfaction

My disease progressed through treatment in 3 months as evidenced by a new bony metastasis. Sorta lives up to it's Kaplan-Meyer curve of an additional 6 months in the intent to treat trials. Overall well tolerated though the hot flashes were difficult as was the constant nausea.

Report this postFill 3Created with Sketch.

IMPORTANT INFORMATION ABOUT USER-GENERATED CONTENT ON WEBMD

The opinions expressed in WebMD User-generated content areas like communities, reviews, ratings, or blogs are solely those of the User, who may or may not have medical or scientific training. These opinions do not represent the opinions of WebMD. User-generated content areas are not reviewed by a WebMD physician or any member of the WebMD editorial staff for accuracy, balance, objectivity, or any other reason except for compliance with our Terms and Conditions.

Read More